- Report
- November 2023
- 182 Pages
Global
From €4672EUR$4,900USD£3,989GBP
- Report
- October 2023
- 170 Pages
Global
From €4672EUR$4,900USD£3,989GBP
- Report
- November 2023
- 93 Pages
Global
From €2813EUR$2,950USD£2,402GBP
- Report
- November 2023
- 173 Pages
Global
From €4719EUR$4,950USD£4,030GBP
- Report
- November 2023
- 95 Pages
Europe
From €3289EUR$3,450USD£2,809GBP
- Report
- January 2019
- 144 Pages
Global
From €1311EUR$1,375USD£1,119GBP
€2622EUR$2,750USD£2,239GBP
- Report
- September 2023
- 83 Pages
Israel
From €3337EUR$3,500USD£2,849GBP
- Report
- February 2023
- 220 Pages
Global
From €7151EUR$7,500USD£6,106GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €3099EUR$3,250USD£2,646GBP
- Report
- October 2023
- 89 Pages
Egypt
From €3337EUR$3,500USD£2,849GBP
- Report
- October 2023
- 84 Pages
Canada
From €3337EUR$3,500USD£2,849GBP
- Report
- August 2023
- 75 Pages
Israel
From €3337EUR$3,500USD£2,849GBP
- Report
- August 2022
- 115 Pages
Global
From €4290EUR$4,500USD£3,664GBP
- Report
- August 2022
- 120 Pages
Global
From €4290EUR$4,500USD£3,664GBP
- Report
- August 2022
- 117 Pages
Global
From €4290EUR$4,500USD£3,664GBP
- Report
- October 2018
- 17 Pages
Global
From €9534EUR$10,000USD£8,141GBP
- Report
- October 2018
- 16 Pages
Global
From €9534EUR$10,000USD£8,141GBP
- Drug Pipelines
- February 2018
- 11 Pages
Global
From €9534EUR$10,000USD£8,141GBP
- Report
- February 2018
- 11 Pages
Global
From €9534EUR$10,000USD£8,141GBP
- Report
- February 2022
- 120 Pages
Global
From €2384EUR$2,500USD£2,035GBP
The Vasodilator market is a segment of the Medical Devices industry that focuses on the development and sale of products used to widen blood vessels. These products are used to treat a variety of conditions, including hypertension, coronary artery disease, and peripheral vascular disease. Vasodilators are typically administered through injection, infusion, or inhalation, and can be used to reduce blood pressure, improve blood flow, and reduce the risk of stroke and heart attack.
The Vasodilator market is highly competitive, with a number of large and small companies offering a variety of products. Major players in the market include Pfizer, Merck, Novartis, and Sanofi, while smaller companies such as Bausch Health, Mylan, and Teva Pharmaceuticals also offer products. Additionally, many generic drug manufacturers produce generic versions of popular vasodilators. Show Less Read more